Facebook
X
LinkedIn
Forward
2026 Surgical Oncology Cancer Symposium
The University of Tennessee Health Science Center Department of Surgery, Division of Surgical Oncology is hosting a one-day symposium on the management of soft tissue sarcoma. The purpose of this activity is to educate healthcare professionals on up-to-date strategies for the evaluation and management of patients with these musculoskeletal tumors. The symposium will provide a unique opportunity for clinicians involved in the care of these patients to learn from and interact with leading national and local faculty to increase clinical knowledge, apply new data into practice, and ultimately improve patient outcomes.
Target Audience
- Surgical Oncology
- Orthopedic Oncology
- Medical Oncology
- Radiation Oncology
- Pathology
- Physicians
- Advanced Practice Providers
- Residents
- Fellows
- Medical Students
Professional Practice Gap
Current practice gaps and unmet educational needs in soft tissue sarcoma management include limited familiarity with evolving molecular diagnostics and the growing role of genomic profiling in treatment selection. Clinicians also face challenges integrating surgery, systemic therapy, and radiation therapy into coordinated multidisciplinary treatment plans, particularly regarding neoadjuvant versus adjuvant approaches. Additional gaps exist in understanding the role of radiation therapy for extremity, retroperitoneal, and recurrent sarcomas. Because sarcomas are rare and heterogeneous malignancies, many providers have limited exposure to complex presentations, contributing to variability in management and referral patterns. Improved multidisciplinary collaboration among pathology, surgery, orthopedic oncology, medical oncology, and radiation oncology remains essential to optimize evidence-based care and patient outcomes.
Learning Objectives
- Apply contemporary histopathologic and molecular diagnostic principles in the classification of soft tissue sarcomas to improve diagnostic accuracy, prognostication, and treatment selection.
- Differentiate multidisciplinary treatment strategies for major sarcoma subtypes, including gastrointestinal stromal tumors (GIST), retroperitoneal sarcomas, and extremity soft tissue sarcomas, based on histology, stage, and disease location.
- Evaluate the appropriate use of systemic therapy, surgery, and radiation therapy in the neoadjuvant, adjuvant, and metastatic settings for patients with soft tissue sarcoma.
- Incorporate evidence-based surgical decision-making regarding limb-sparing approaches, multivisceral resection, margin optimization, and management of locally recurrent disease.
- Integrate multidisciplinary case-based decision-making to optimize individualized treatment planning, functional outcomes, local control, and long-term survivorship in patients with sarcoma.
*** This live activity has been approved for up to 4.75 AMA PRA Category 1 CreditsTM. ****
| 2026 Surgical Oncology Cancer Symposium | ||
| Updates in the Multidisciplinary Management of Soft Tissue Sarcoma | ||
| FedEx Event Center - Saturday, November 14, 2026 | ||
| Timeslot | Presentation | Presenter |
| 7:30 - 7:50 AM | Continental Breakfast | |
| 7:50 - 8:00 AM | Welcome and Conference Objectives: | Paxton Dickson, MD |
| Goals of Multidisciplinary Sarcoma Care | Conference Chair (Surgical Oncology) | |
| Overview of Conference Structure and Case-Based Discussions | ||
| 8:00 - 8:30 AM | Histology, Molecular Pathology, and Genomics of Soft Tissue Sarcoma | Kurt T. Patton, MD |
| 8:30 - 9:00 AM | Medical Oncology: Systemic Therapy for Soft Tissue Sarcoma | Elizabeth Davis, MD |
| 9:00 - 9:30 AM | Current Concepts in Radiation Therapy for Soft Tissue Sarcomas | Arash O. Naghavi, MD, MS |
| 9:30 - 9:45 AM | Question and Answer | |
| 9:45 - 10:15 AM | Break | |
| 10:15 - 10:45 AM | Retroperitoneal Sarcoma: Surgical & Multidisciplinary Strategies | Chelsea Olson, MD |
| 10:45 - 11:15 AM | Extremity Sarcoma: Limb Salvage, Margins, and Function | Michael Neel, MD |
| 11:15 - 11:45 AM | Gastrointestinal Stromal Tumors (GIST): Multidisciplinary Management | David Portnoy, MD & Ian Solsky, MD |
| 11:45 - 12:00 AM | Question and Answer | |
| 12:00 - 1:00 PM | Lunch / Visit with Exhibitors | |
| 1:00 - 1:30 PM | Considerations in the Management of Pediatric Sarcomas | Alberto Pappo, MD |
| 1:30 - 2:30 PM | Multidisciplinary Case-Based Panel - Surgical Oncology, Orthopedic Oncology, Medical Oncology, Radiation Oncology, Pathology | Paxton Dickson, MD - Moderator |
| 2:30 - 2:35 PM | Closing Remarks and Adjournment | Paxton Dickson, MD |
| Total CME | 4.75 hours (4 hours and 45 minutes) | |
Parking
The FedEx Event Center at Shelby Farms Park offers ample, convenient, and free on-site parking. The venue features dedicated parking spaces directly off Walnut Grove Road and adjacent to the building for each access to events.
AMA Credit Designation: The University of Tennessee College of Medicine (UTCOM) designates this live activity for a maximum of
4.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education for Non-Physicians: The UTCOM will issue Certificates of Participation to non-physicians for participating in this activity and designates it for CEUs using the national standard that 1 hour of educational instruction is awarded .1 CEU.
Accreditation: The UTCOM is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Available Credit
- 4.75 AMA PRA Category 1 Credit™
- 4.75 Attendance